Hunan Hansen Pharmaceutical Co Ltd Working Capital to Net Assets Ratio

Latest as of March 2026: 45.0%

Hunan Hansen Pharmaceutical Co Ltd working capital to net assets ratio. Hunan Hansen Pharmaceutical Co Ltd (002412) has a Working Capital to Net Assets ratio of 45.0% as of March 2026. Working capital of CN¥1.09 Billion (current assets of CN¥1.38 Billion minus current liabilities of CN¥287.17 Million) is measured against net assets of CN¥2.42 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Hunan Hansen Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

45.0%
Working Capital / Net Assets

Working Capital

CN¥1.09 Billion
CNY

Current Assets

CN¥1.38 Billion
CNY

Current Liabilities

CN¥287.17 Million
CNY

Working Capital to Net Assets Ratio of Hunan Hansen Pharmaceutical Co Ltd (2006–2025)

Working capital to net assets ratio of Hunan Hansen Pharmaceutical Co Ltd from 2006 to 2025. This chart shows how Hunan Hansen Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 45.0%, reflecting working capital of CN¥1.09 Billion against net assets of CN¥2.42 Billion CNY. See 002412 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Hunan Hansen Pharmaceutical Co Ltd Working Capital to Net Assets Ratio by Year (2006–2025)

Hunan Hansen Pharmaceutical Co Ltd working capital to net assets ratio by year from 2006 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Hunan Hansen Pharmaceutical Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 002412 total asset value.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2025 43.4% CN¥1.03 Billion CN¥2.38 Billion CN¥1.32 Billion CN¥288.33 Million ▲ +6.9 pp
2024 36.5% CN¥804.85 Million CN¥2.20 Billion CN¥1.12 Billion CN¥318.32 Million ▲ +9.0 pp
2023 27.5% CN¥540.65 Million CN¥1.96 Billion CN¥896.07 Million CN¥355.42 Million ▲ +1.9 pp
2022 25.6% CN¥485.17 Million CN¥1.89 Billion CN¥865.40 Million CN¥380.24 Million ▲ +15.0 pp
2021 10.6% CN¥184.30 Million CN¥1.74 Billion CN¥535.41 Million CN¥351.11 Million ▼ -5.4 pp
2020 15.9% CN¥254.03 Million CN¥1.59 Billion CN¥527.46 Million CN¥273.43 Million ▼ -0.9 pp
2019 16.8% CN¥257.34 Million CN¥1.53 Billion CN¥593.86 Million CN¥336.52 Million ▲ +11.4 pp
2018 5.4% CN¥73.56 Million CN¥1.36 Billion CN¥490.94 Million CN¥417.38 Million ▲ +2.5 pp
2017 2.9% CN¥35.16 Million CN¥1.22 Billion CN¥497.08 Million CN¥461.93 Million ▼ -3.9 pp
2016 6.7% CN¥84.87 Million CN¥1.26 Billion CN¥482.03 Million CN¥397.16 Million ▼ -35.5 pp
2015 42.3% CN¥529.76 Million CN¥1.25 Billion CN¥637.99 Million CN¥108.23 Million ▲ +3.1 pp
2014 39.2% CN¥452.19 Million CN¥1.15 Billion CN¥646.19 Million CN¥194.00 Million ▼ -2.8 pp
2013 42.0% CN¥465.75 Million CN¥1.11 Billion CN¥628.00 Million CN¥162.25 Million ▼ -37.7 pp
2012 79.7% CN¥769.43 Million CN¥965.11 Million CN¥842.66 Million CN¥73.23 Million ▼ -8.4 pp
2011 88.1% CN¥778.48 Million CN¥883.65 Million CN¥831.30 Million CN¥52.82 Million ▼ -2.7 pp
2010 90.8% CN¥816.41 Million CN¥898.82 Million CN¥863.26 Million CN¥46.85 Million ▲ +36.4 pp
2009 54.4% CN¥97.62 Million CN¥179.51 Million CN¥164.96 Million CN¥67.34 Million ▲ +15.7 pp
2008 38.6% CN¥50.33 Million CN¥130.26 Million CN¥135.00 Million CN¥84.67 Million ▲ +22.6 pp
2007 16.0% CN¥14.07 Million CN¥87.77 Million CN¥100.56 Million CN¥86.49 Million ▲ +46.1 pp
2006 -30.0% CN¥-20.20 Million CN¥67.28 Million CN¥124.26 Million CN¥144.46 Million —
pp = percentage points